Sirtris Pharmaceuticals
Cambridge
About Sirtris Pharmaceuticals
[Sirtris Pharmaceuticals](http://www.sirtrispharma.com) (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes. via: [Sirtris](http://www.sirtrispharma.com)
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Total funding: $82.0M
- Funding stage: M&A
- Last round: Debt Financing (Apr 2006)
- Ticker: nasdaq:SIRT
- Website: sirtrispharma.com
- Phone: (617) 252-6920
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/sirtris-pharmaceuticals-3053332 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.